Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by North, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by North, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Neurofibromatosis Type 1: Review of the First 200 Patients in an Australian Clinic

Kathryn North, MBBS, BSc(Med)

Department of Neurology, The Children's Hospital, Camperdown, Sydney, Australia

Neurofibromatosis type 1 is a common multisystem disorder, best managed in a multidisciplinary clinic. In 1991, the first Australian neurofibromatosis clinic was established at the Children's Hospital, Camperdown, and the clinical characteristics of the first 150 families are reviewed.

Two hundred individuals were assessed; there was an equal sex distribution, and 55% of cases were sporadic. Advanced paternal age appeared to predispose to new mutations in the neurofibromatosis gene. Café-au-lait spots and axillary freckling were important to the diagnosis of neurofibromatosis type 1 during childhood, and neurofibromas and Lisch nodules, although often not appearing until after puberty, were present in almost all patients over 30 years of age. Short stature (27%), macrocephaly (43%), scoliosis (20.5%), and learning disabilities (45%) were common associated features. The prevalence of disease complications was similar to the major US and European studies. (J Child Neurol 1993;8:395-402).

Journal of Child Neurology, Vol. 8, No. 4, 395-402 (1993)
DOI: 10.1177/088307389300800421
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch DermatolHome page
K. S. Nunley, F. Gao, A. C. Albers, S. J. Bayliss, and D. H. Gutmann
Predictive Value of Cafe au Lait Macules at Initial Consultation in the Diagnosis of Neurofibromatosis Type 1
Arch Dermatol, August 1, 2009; 145(8): 883 - 887.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
H. Chen, Y. Qiu, L. Chen, L. Li, J. Chen, C. Zhang, B. Wang, Y. Yu, Z. Zhu, F. Zhu, et al.
The Expression of Neurofibromin in Human Osteoblasts and Chondrocytes
Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 25 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
A. Devlin
Paediatric neurological examination
Adv. Psychiatr. Treat., March 1, 2003; 9(2): 125 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
T. Rosser and R. J. Packer
Review Article : Neurofibromas in Children With Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 585 - 591.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
R. M. Costa and A. J. Silva
Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 622 - 626.
[Abstract] [PDF]

Home page
 J. Med. Genet.Home page
M POYHONEN
A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in northern Finland
J. Med. Genet., December 1, 2000; 37(12): 43e - 43.
[Full Text]

Home page
 PediatricsHome page
K. DeBella, J. Szudek, and J. M. Friedman
Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children
Pediatrics, March 1, 2000; 105(3): 608 - 614.
[Abstract] [Full Text]

Home page
 PediatricsHome page
D. Carmi, M. Shohat, A. Metzker, and Z. Dickerman
Growth, Puberty, and Endocrine Functions in Patients With Sporadic or Familial Neurofibromatosis Type 1: A Longitudinal Study
Pediatrics, June 1, 1999; 103(6): 1257 - 1262.
[Abstract] [Full Text]

Home page
 JAMAHome page
D. H. Gutmann, A. Aylsworth, J. C. Carey, B. Korf, J. Marks, R. E. Pyeritz, A. Rubenstein, and D. Viskochil
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA, July 2, 1997; 278(1): 51 - 57.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
A. Zvulunov, Y. Barak, and A. Metzker
Juvenile Xanthogranuloma, Neurofibromatosis, and Juvenile Chronic Myelogenous Leukemia: World Statistical Analysis
Arch Dermatol, August 1, 1995; 131(8): 904 - 908.
[Abstract] [PDF]